The store will not work correctly when cookies are disabled.
N-(6-Fluorobenzothiazol-2-yl)-5-(p-tolyl)furan-2-carboxamide
ID: ALA4475561
PubChem CID: 155537985
Max Phase: Preclinical
Molecular Formula: C19H13FN2O2S
Molecular Weight: 352.39
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccc(-c2ccc(C(=O)Nc3nc4ccc(F)cc4s3)o2)cc1
Standard InChI: InChI=1S/C19H13FN2O2S/c1-11-2-4-12(5-3-11)15-8-9-16(24-15)18(23)22-19-21-14-7-6-13(20)10-17(14)25-19/h2-10H,1H3,(H,21,22,23)
Standard InChI Key: CUCNBWASSZITNW-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
14.5058 -2.2080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5046 -3.0276 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2127 -3.4365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2109 -1.7992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9195 -2.2044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9243 -3.0230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7043 -3.2715 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
17.1817 -2.6064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6966 -1.9470 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.9989 -2.6015 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.4116 -3.3068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2288 -3.3020 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0072 -4.0169 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.7966 -3.4356 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
19.7095 -3.9627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4852 -3.7056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4804 -2.8884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7017 -2.6406 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.1403 -2.4053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8893 -2.7349 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5471 -2.2513 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4572 -1.4382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7038 -1.1110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0491 -1.5966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1148 -0.9531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
8 10 1 0
10 11 1 0
11 12 1 0
11 13 2 0
2 14 1 0
12 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 12 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
17 19 1 0
22 25 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 352.39 | Molecular Weight (Monoisotopic): 352.0682 | AlogP: 5.26 | #Rotatable Bonds: 3 |
Polar Surface Area: 55.13 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 9.98 | CX Basic pKa: ┄ | CX LogP: 5.17 | CX LogD: 5.17 |
Aromatic Rings: 4 | Heavy Atoms: 25 | QED Weighted: 0.55 | Np Likeness Score: -2.42 |
References
1. Zaldivar-Diez J, Li L, Garcia AM, Zhao WN, Medina-Menendez C, Haggarty SJ, Gil C, Morales AV, Martinez A.. (2020) Benzothiazole-Based LRRK2 Inhibitors as Wnt Enhancers and Promoters of Oligodendrocytic Fate., 63 (5): [PMID:31825616] [10.1021/acs.jmedchem.9b01752] |